Prolactinoma and pregnancy – a series of cases including pituitary apoplexy

References

• Auriemma RS, Perone Y, Di Sarno A, Grasso LF, Guerra E, Gasperi M, et al. 2013. Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation. The Journal of Clinical Endocrinology & Metabolism 98:372–379.
   PubMed Web of Science ®Google Scholar
• Colao A, Abs R, Bárcena DG, Chanson P, Paulus W, Kleinberg DL. 2008. Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. Clinical Endocrinology (Oxford) 68:66.
   PubMed Web of Science ®Google Scholar
• Colao A, Di Sarno A, Sarnacchiaro F, Ferone D, Di Renzo G, Merola B, et al. 1997. Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. The Journal of Clinical Endocrinology & Metabolism 82:876–883.
   PubMed Web of Science ®Google Scholar
• Dinc H, Esen F, Demirci A, Sari A, Resit Gümele H. 1998. Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment. Acta Radiologica 39:64–69.
   PubMed Web of Science ®Google Scholar
• Elster AD, Sanders TG, Vines FS, Chen MY. 1991. Size and shape of the pituitary gland during pregnancy and post partum: measurement with MR imaging. Radiology 181:531–535.
   PubMed Web of Science ®Google Scholar
• Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, et al. 2004. The prevalence of pituitary adenomas: a systematic review. Cancer 101:613–619.
   PubMed Web of Science ®Google Scholar
• Gemzell C, Wang CF. 1979. Outcome of pregnancy in women with pituitary adenoma. Fertility and Sterility 31:363–372.
   PubMed Web of Science ®Google Scholar
• Goluboff LG, Ezrin C. 1969. Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis. The Journal of Clinical Endocrinology & Metabolism 29:1533–1538.
   PubMed Web of Science ®Google Scholar
• Koppelman MC, Jaffe MJ, Rieth KG, Caruso RC, Loriaux DL. 1984. Hyperprolactinemia, amenorrhea, and galactorrhea. A retrospective assessment of twenty-five cases. Annals of Internal Medicine 100:115–121.
   PubMed Web of Science ®Google Scholar
• Krupp P, Monka C. 1987. Bromocriptine in pregnancy: safety aspects. Wiener Klinische Wochenschrift 65:823–827.
   Web of Science ®Google Scholar
• Krupp P, Monka C, Richter K. 1988. The safety aspects of infertility treatments. Programme of the Second World Congress of Gynaecology and Obstetrics. Rio de Janeiro, Brazil.
   Google Scholar
• Kupersmith MJ, Rosenberg C, Kleinberg D. 1994. Visual loss in pregnant women with pituitary adenomas. Annals of Internal Medicine 121:473–477.
   PubMed Web of Science ®Google Scholar
• Lebbe M, Hubinont C, Bernard P, Maiter D. 2010. Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. Clinical Endocrinology (Oxford) 73:236.
   PubMed Web of Science ®Google Scholar
• March CM, Kletzky OA, Davajan V, Teal J, Weiss M, Apuzzo ML, et al. 1981. Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas. American Journal of Obstetrics and Gynecology 139:835–844.
   PubMed Web of Science ®Google Scholar
• Maurer RA. 1982. Relationship between estradiol, ergocryptine, and thyroid hormone: effects on prolactin synthesis and prolactin messenger ribonucleic acid levels. Endocrinology 110:1515–1520.
   PubMed Web of Science ®Google Scholar
• Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. 2011. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 96:273.
   PubMed Web of Science ®Google Scholar
• Miki Y, Asato R, Okumura R, et al. 1993. Anterior pituitary gland in pregnancy: hyperintensity at MR. Radiology 187:229–231.
   PubMed Web of Science ®Google Scholar
• Molitch ME. 1999. Management of prolactinomas during pregnancy. The Journal of Reproductive Medicine 44:1121–1126.
   PubMed Web of Science ®Google Scholar
• Molitch ME. 2010. Prolactinomas and pregnancy. Clinical Endocrinology (Oxford) 73:147–148.
   PubMed Web of Science ®Google Scholar
• Ono M, Miki N, Amano K, Kawamata T, Seki T, Makino R, et al. 2010. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas . The Journal of Clinical Endocrinology & Metabolism 95:2672.
   PubMed Web of Science ®Google Scholar
• Pichon MF, Bression D, Peillon F, Milgrom E. 1980. Oestrogen receptors in human pituitary adenomas. The Journal of Clinical Endocrinology & Metabolism 51:897–902.
   PubMed Web of Science ®Google Scholar
• Rivera JL, Lal S, Ettigi P, Hontela S, Muller HF, Friesen HG. 1976. Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups. Clinical Endocrinology (Oxford) 5:273–282.
   PubMed Web of Science ®Google Scholar
• Schlechte JA. 2003. Clinical practice. Prolactinoma. The New England Journal of Medicine 349:2035–2041.
   PubMed Web of Science ®Google Scholar
• Serri O. 1994. Progress in the management of hyperprolactinemia. The New England Journal of Medicine 331:942–944.
   PubMed Web of Science ®Google Scholar
• Sisam DA, Sheehan JP, Sheeler LR. 1987. The natural history of untreated microprolactinomas. Fertility and Sterility 48:67–71.
   PubMed Web of Science ®Google Scholar
• Vician L, Shupnik MA, Gorski J. 1979. Effects of estrogen on primary ovine pituitary cell cultures: stimulation of prolactin secretion, synthesis, and preprolactin messenger ribonucleic acid activity. Endocrinology 104:736–743.
   PubMed Web of Science ®Google Scholar
• Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF. 1994. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. The New England Journal of Medicine 331:904–909.
   PubMed Web of Science ®Google Scholar
• Witek P, Zieliński G, Maksymowicz M, Zgliczyński W. 2012. Transsphenoidal surgery for a life-threatening prolactinoma apoplexy during pregnancy. Neuro Endocrinology Letters 33:483–488.
   PubMed Web of Science ®Google Scholar